These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 21750307)

  • 1. TDM-guided therapy with daptomycin and meropenem in a morbidly obese, critically ill patient.
    Pea F; Cojutti P; Sbrojavacca R; Cadeo B; Cristini F; Bulfoni A; Furlanut M
    Ann Pharmacother; 2011 Jul; 45(7-8):e37. PubMed ID: 21750307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using vancomycin concentrations for dosing daptomycin in a morbidly obese patient with renal insufficiency.
    Pai MP; Mercier RC; Allen SE
    Ann Pharmacother; 2006 Mar; 40(3):553-8. PubMed ID: 16507618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety and effectiveness of daptomycin across a hospitalized obese population: results of a multicenter investigation in the southeastern United States.
    Bookstaver PB; Bland CM; Qureshi ZP; Faulkner-Fennell CM; Sheldon MA; Caulder CR; Hartis C;
    Pharmacotherapy; 2013 Dec; 33(12):1322-30. PubMed ID: 23712701
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful treatment of polymicrobial calcaneal osteomyelitis with telavancin, rifampin, and meropenem.
    Brinkman MB; Fan K; Shiveley RL; Van Anglen LJ
    Ann Pharmacother; 2012 Jun; 46(6):e15. PubMed ID: 22619476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of daptomycin in patients with renal impairment: a multicenter retrospective analysis.
    Kullar R; McClellan I; Geriak M; Sakoulas G
    Pharmacotherapy; 2014 Jun; 34(6):582-9. PubMed ID: 24658897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meropenem by continuous versus intermittent infusion in ventilator-associated pneumonia due to gram-negative bacilli.
    Lorente L; Lorenzo L; Martín MM; Jiménez A; Mora ML
    Ann Pharmacother; 2006 Feb; 40(2):219-23. PubMed ID: 16449546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety of high-dose intravenous daptomycin treatment: three-year cumulative experience in a clinical program.
    Figueroa DA; Mangini E; Amodio-Groton M; Vardianos B; Melchert A; Fana C; Wehbeh W; Urban CM; Segal-Maurer S
    Clin Infect Dis; 2009 Jul; 49(2):177-80. PubMed ID: 19500039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute seizures due to a probable interaction between valproic acid and meropenem.
    Coves-Orts FJ; Borrás-Blasco J; Navarro-Ruiz A; Murcia-López A; Palacios-Ortega F
    Ann Pharmacother; 2005 Mar; 39(3):533-7. PubMed ID: 15701769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased meropenem levels in Intensive Care Unit patients with augmented renal clearance: benefit of therapeutic drug monitoring.
    Tröger U; Drust A; Martens-Lobenhoffer J; Tanev I; Braun-Dullaeus RC; Bode-Böger SM
    Int J Antimicrob Agents; 2012 Oct; 40(4):370-2. PubMed ID: 22795654
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daptomycin therapy for vancomycin-resistant enterococcal bacteremia: a retrospective case series of 30 patients.
    Gallagher JC; Perez ME; Marino EA; LoCastro LG; Abrardo LA; MacDougall C
    Pharmacotherapy; 2009 Jul; 29(7):792-9. PubMed ID: 19558253
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cephalexin failure rates in morbidly obese patients with cellulitis.
    Kaufman KR; Thurber KM; O'Meara JG; Langworthy DR; Kashiwagi DT
    J Clin Pharm Ther; 2016 Aug; 41(4):409-13. PubMed ID: 27193482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of Serratia marcescens meningitis with prolonged infusion of meropenem.
    Nicasio AM; Quintiliani R; DeRyke CA; Kuti JL; Nicolau DP
    Ann Pharmacother; 2007 Jun; 41(6):1077-81. PubMed ID: 17472997
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of meropenem in critically ill patients with severe infections.
    Binder L; Schwörer H; Hoppe S; Streit F; Neumann S; Beckmann A; Wachter R; Oellerich M; Walson PD
    Ther Drug Monit; 2013 Feb; 35(1):63-70. PubMed ID: 23318279
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Successful treatment of infective panniculitis with daptomycin in a pregnant, morbidly obese patient.
    Klibanov OM; Vickery S; Nortey C
    Ann Pharmacother; 2014 May; 48(5):652-5. PubMed ID: 24586060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and pharmacodynamics of continuous infusion meropenem in overweight, obese, and morbidly obese patients with stable and unstable kidney function: a step toward dose optimization for the treatment of severe gram-negative bacterial infections.
    Pai MP; Cojutti P; Pea F
    Clin Pharmacokinet; 2015 Sep; 54(9):933-41. PubMed ID: 25850987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of concomitant administration of meropenem and valproic acid in an elderly Chinese patient.
    Gu J; Huang Y
    Am J Geriatr Pharmacother; 2009 Feb; 7(1):26-33. PubMed ID: 19281938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety of daptomycin in patients receiving hemodialysis.
    Mueller BA; Crompton JA; Donovan BJ; Yankalev S; Lamp KC
    Pharmacotherapy; 2011 Jul; 31(7):665-72. PubMed ID: 21923453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics and pharmacodynamics of meropenem in febrile neutropenic patients with bacteremia.
    Ariano RE; Nyhlén A; Donnelly JP; Sitar DS; Harding GK; Zelenitsky SA
    Ann Pharmacother; 2005 Jan; 39(1):32-8. PubMed ID: 15598967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacokinetics of daptomycin in moderately obese, morbidly obese, and matched nonobese subjects.
    Dvorchik BH; Damphousse D
    J Clin Pharmacol; 2005 Jan; 45(1):48-56. PubMed ID: 15601805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.